Prevalence of Subclinical Coronary Atherosclerosis in the General Population

Early detection of coronary artery disease (CAD) using computed tomography (CT) and calcium score (CAC) might help plan prevention strategies years in advance. This study used CT to determine the prevalence and characteristics of atherosclerosis in the general population. 

aterosclerosis coronaria subclínica

Non-contrast images were scored for CAC. After that, all images with atherosclerosis potential were assessed segment by segment. Segments were divided into: absence of atherosclerosis, 1 to 49% stenosis, and >50% stenosis.

The amazing number of 25,182 totally unaware CAD patients between 50 and 64 years of age were included.

Nearly half of them (42.1%) presented CT findings of CAD; >50% lesions was found in 5.2% of them; and left main lesions, proximal left anterior descending or 3 vessel disease were found in 1.9% of cases. And if this was not enough, 8.3% presented non-calcified plaque. 

Disease was more prevalent the older patients, and the more proximal the segments were. 

All individuals with >400 calcium score presented CAD and half of these presented significant stenosis (as expected).


Read also: TAVR and Anticoagulation: Direct Anticoagulant Agents or Vitamin K Inhibitors?


However, patients with 0 CAC showed 5.5% stenosis and 0.4% obstructive stenosis. 0 CAC in addition to increased risk of CAD lead us to 9.2% stenosis, confirmed by CT.

Conclusion

CT has shown atherosclerosis is present in nearly half of a seemingly healthy population. High CAC guarantees CAD findings, but 0 CAC offers no guarantees. 

CIRCULATIONAHA-121-055340

Original Title: Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population.

Reference: Göran Bergström et al. Circulation. 2021;144:916–929. DOI: 10.1161/CIRCULATIONAHA.121.055340.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...